SLC6A3, solute carrier family 6 member 3, 6531

N. diseases: 373; N. variants: 38
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0011206
Disease: Delirium
Delirium
0.360 Biomarker disease PSYGENET Adjusted for age, cognitive impairment, and functional impairment, three SNPs in the DRD2 gene and seven SNPs in the SLC6A3 gene were associated with delirium; none of these associations was significant after correction for multiple testing. 19309018 2010
CUI: C0011206
Disease: Delirium
Delirium
0.360 GeneticVariation disease BEFREE Adjusted for age, cognitive impairment, and functional impairment, three SNPs in the DRD2 gene and seven SNPs in the SLC6A3 gene were associated with delirium; none of these associations was significant after correction for multiple testing. 19309018 2010
CUI: C0011206
Disease: Delirium
Delirium
0.360 Biomarker disease PSYGENET The SLC6A3 rs393795 homozygous AA genotype was more frequent in patients without delirium in all populations. 19739106 2010
CUI: C0011206
Disease: Delirium
Delirium
0.360 GeneticVariation disease BEFREE The SLC6A3 rs393795 homozygous AA genotype was more frequent in patients without delirium in all populations. 19739106 2010
CUI: C0011206
Disease: Delirium
Delirium
0.360 Biomarker disease PSYGENET Dopamine transporter levels were below the range of values measured in age-matched controls, providing pathologic evidence for increased risk of chaotic dopamine signaling in excited delirium. 19541436 2009
CUI: C0011206
Disease: Delirium
Delirium
0.360 GeneticVariation disease BEFREE Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. 15823165 2005
CUI: C0011206
Disease: Delirium
Delirium
0.360 Biomarker disease PSYGENET Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. 15823165 2005
CUI: C0011206
Disease: Delirium
Delirium
0.360 Biomarker disease PSYGENET The present study tests the hypothesis that the 9-repeat allele of the dopamine transporter gene (DAT1; SLC6A3) is more frequent in alcohol-dependent probands--and in particular those with severe withdrawal symptoms (seizures and/or delirium)--compared to nonalcoholics. 10088054 1999
CUI: C0011206
Disease: Delirium
Delirium
0.360 AlteredExpression disease BEFREE In contrast, DAT gene expression was altered significantly in cocaine abusers at risk for agitated delirium. 10581411 1999
CUI: C0011206
Disease: Delirium
Delirium
0.360 GeneticVariation disease BEFREE The present study tests the hypothesis that the 9-repeat allele of the dopamine transporter gene (DAT1; SLC6A3) is more frequent in alcohol-dependent probands--and in particular those with severe withdrawal symptoms (seizures and/or delirium)--compared to nonalcoholics. 10088054 1999
CUI: C0011206
Disease: Delirium
Delirium
0.360 GeneticVariation disease BEFREE Analyzing a VNTR polymorphism in the 3' untranslated region of DAT1, we found a significantly increased prevalence of the nine-repeat allele in 93 alcoholics displaying withdrawal seizures or delirium, compared with 93 ethnically matched nonalcoholic controls (p = 0.003; OR = 2.44; 95% confidence interval: 1.35-4.43). 9024952 1997